"Lebrikizumab Clears Eczema Skin Rapidly, Safely" - Kevin Kunzmann
Novel monoclonal antibody lebrikizumab was shown to significantly benefit adults with moderate to severe atopic dermatitis (eczema) in new phase 2b data evidencing the interleukin 13 (IL-13)-targeting therapy.
Press Release
New Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation
Dec 21, 2023 View All Press ReleasesPress Release
New RNA-based Therapy Combats Melanoma in Mouse Models
Jul 27, 2023 View All Press Releases